Walleye Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Walleye Trading’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-230	Closed	-$26.7K	–	5238
2020 Q3	$26K	Buy	+230	New	+$24.7K	﹤0.01%	3795
2019 Q4	–	Sell	-3,116	Closed	-$361K	–	4877
2019 Q3	$357K	Buy	+3,116	New	+$310K	﹤0.01%	2441
2016 Q4	–	Sell	-700	Closed	-$87K	–	5526
2016 Q3	$87K	Buy	700 +600	+600%	+$70.8K	﹤0.01%	3395
2016 Q2	$11K	Buy	+100	New	+$11.6K	﹤0.01%	4802
2015 Q4	–	Sell	-1,200	Closed	-$108K	–	6034
2015 Q3	$108K	Buy	1,200 +1,100	+1,100%	+$116K	﹤0.01%	2888
2015 Q2	$12K	Buy	+100	New	+$10.5K	﹤0.01%	4244

Walleye Trading's CBPO Position: Q4 2020 in Review

Walleye Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 230 shares — an estimated $26.7K sold.

Walleye Trading first reported a position in CBPO in Q2 2015 and held it in 6 quarters. The position peaked at $357K in Q3 2019. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Walleye Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 230 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $26.7K.
Walleye Trading first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 6 quarters.
Walleye Trading's China Biologic Products Holdings, Inc. position peaked at $357K in Q3 2019.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.